FREE RAC Regulatory Strategic Planning Questions and Answers

Question 1

A pharmaceutical company is developing a novel drug-eluting stent, a product combining a drug and a device. To formulate an effective regulatory strategy in the United States, what is the MOST critical initial step?

Accepted Answer

Submitting a Request for Designation (RFD) to the Office of Combination Products (OCP) to determine the product's Primary Mode of Action (PMOA).

Answer

For a combination product like a drug-eluting stent, the most critical first step in regulatory strategy is to determine the Primary Mode of Action (PMOA). The PMOA dictates which FDA center (CDER, CBER, or CDRH) will have primary review jurisdiction. The Office of Combination Products (OCP) is responsible for this assignment. If the PMOA is unclear, a sponsor should submit a Request for Designation (RFD) to the OCP for a formal determination, which is fundamental to defining the entire regulatory pathway.

Question 2

A company is creating a global regulatory strategy for a new Class II medical device. Which of the following activities is essential to perform during the earliest stages of strategic planning?

Accepted Answer

Identifying and defining the device's intended use and target patient population.

Answer

The foundational step in any global regulatory strategy is to clearly define the device, which includes its intended use and target population. This information is critical as it directly influences the device's classification, the selection of appropriate regulatory pathways in different markets, and the scope of required clinical evidence. All subsequent strategic decisions build upon this initial definition.

Question 3

Which of the following BEST describes the role of a Target Product Profile (TPP) in regulatory strategic planning?

Accepted Answer

It is a dynamic, strategic tool that outlines the desired product characteristics to guide development and facilitate alignment with regulatory authorities.

Answer

A Target Product Profile (TPP) is a strategic planning tool that outlines the desired characteristics of a product. It is intended to be a 'living document' that evolves as new data becomes available. Its purpose is to guide internal development decisions and facilitate productive discussions with regulatory authorities, ensuring that the development program is aligned with regulatory expectations and clinical needs from an early stage.

Question 4

A biotech company is developing a new biologic therapy for a serious, life-threatening disease with no current effective treatment. To potentially shorten the time to market, the company's regulatory strategy should prioritize:

Accepted Answer

Evaluating the criteria for one of the FDA's expedited programs, such as Breakthrough Therapy or Fast Track designation.

Answer

The FDA offers several expedited programs to facilitate and hasten the development and review of drugs and biologics that treat serious conditions and fill an unmet medical need. Programs like Fast Track and Breakthrough Therapy Designation are specifically designed for situations like the one described, offering benefits such as more frequent FDA meetings and the potential for accelerated approval and priority review. A key part of strategic planning is to determine if a product qualifies for any of these pathways.

Question 5

When developing a regulatory strategy, what is the primary purpose of pre-submission meetings and other formal interactions with health authorities?

Accepted Answer

To gain clarity on regulatory expectations, obtain guidance on the development plan, and de-risk the submission process.

Answer

Formal interactions with health authorities, such as pre-submission meetings, are a critical component of regulatory strategy. Their main purpose is to allow sponsors to present their development plan and receive feedback, ask specific questions, and gain alignment on key issues before a formal marketing application is submitted. This proactive communication helps to identify and mitigate potential hurdles, clarify regulatory expectations, and ultimately reduce the risk of major delays or rejection during the review process.

(RAC) Regulatory Affairs Certification Practice Test

(RAC) Regulatory Affairs Certification Practice Test

FREE RAC Regulatory Strategic Planning Questions and Answers